SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma pulls out from the race to acquire Swedish firm Meda Pharma

04 Jul 2013 Evaluate

Sun Pharmaceutical Industries, which has cash balance of $1.3 billion as on March this year including its subsidiary Taro Pharmaceutical Industries, was in talks with banks to raise funds for the acquisition of Swedish firm Meda Pharmaceuticals for up to $6 billion in June. However, on account of sharp depreciation of rupee in June and patent settlement worth $550 million in the US, has opted out from the race.

Rupee’s sharp fall in June has postponed the overseas acquisition plans of many Indian companies, including Sun Pharma. The rupee leads the losers' chart among Asian currencies in the April-June quarter by plunging 8.6%, during the period due to massive capital outflows on worries of withdrawal of the US stimulus and reported cash crunch in China.

Sun Pharmaceuticals Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1675.20 -17.95 (-1.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×